325 related articles for article (PubMed ID: 16002663)
1. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2.
Kang HK; Lee HY; Kim MK; Park KS; Park YM; Kwak JY; Bae YS
J Immunol; 2005 Jul; 175(2):685-92. PubMed ID: 16002663
[TBL] [Abstract][Full Text] [Related]
2. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation.
Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ
J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of formyl peptide receptor family in human NK cells.
Kim SD; Kim JM; Jo SH; Lee HY; Lee SY; Shim JW; Seo SK; Yun J; Bae YS
J Immunol; 2009 Nov; 183(9):5511-7. PubMed ID: 19843937
[TBL] [Abstract][Full Text] [Related]
4. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
[TBL] [Abstract][Full Text] [Related]
5. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
[TBL] [Abstract][Full Text] [Related]
6. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
7. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38.
Xie J; Qian J; Wang S; Freeman ME; Epstein J; Yi Q
J Immunol; 2003 Nov; 171(9):4792-800. PubMed ID: 14568957
[TBL] [Abstract][Full Text] [Related]
8. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
9. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
[TBL] [Abstract][Full Text] [Related]
10. Trp-Lys-Tyr-Met-Val-Met stimulates phagocytosis via phospho-lipase D-dependent signaling in mouse dendritic cells.
Lee HY; Kang HK; Jo EJ; Kim JI; Lee YN; Lee SH; Park YM; Ryu SH; Kwak JY; Bae YS
Exp Mol Med; 2004 Apr; 36(2):135-44. PubMed ID: 15150442
[TBL] [Abstract][Full Text] [Related]
11. Activation of formyl peptide receptor-like 1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxide.
Jo EJ; Lee HY; Kim JI; Kang HK; Lee YN; Kwak JY; Bae YS
Life Sci; 2004 Sep; 75(18):2217-32. PubMed ID: 15325847
[TBL] [Abstract][Full Text] [Related]
12. The synthetic chemoattractant peptide, Trp-Lys-Tyr-Met-Val-D-Met, enhances monocyte survival via PKC-dependent Akt activation.
Bae YS; Kim Y; Park JC; Suh PG; Ryu SH
J Leukoc Biol; 2002 Feb; 71(2):329-38. PubMed ID: 11818455
[TBL] [Abstract][Full Text] [Related]
13. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
[TBL] [Abstract][Full Text] [Related]
14. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
[TBL] [Abstract][Full Text] [Related]
15. Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells.
Tae YM; Park HT; Moon HG; Kim YS; Jeon SG; Roh TY; Bae YS; Gho YS; Ryu SH; Kwon HS; Kim YK
J Immunol; 2012 Feb; 188(4):1799-808. PubMed ID: 22262660
[TBL] [Abstract][Full Text] [Related]
16. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and thermodynamic analyses of adhesion of a peptide, Trp-Lys-Tyr-Met-Val-D-Met (WKYMVm), and human formyl peptide receptor (hFPR).
Cho JH; Cho K; Shin HS
Biotechnol Lett; 2010 Jun; 32(6):773-9. PubMed ID: 20221845
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells.
Lyakh LA; Sanford M; Chekol S; Young HA; Roberts AB
J Immunol; 2005 Feb; 174(4):2061-70. PubMed ID: 15699136
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
Wan HX; Zhou C; Zhang Y; Sun M; Wang X; Yu H; Yang X; Ye RD; Shen JK; Wang MW
Biochem Pharmacol; 2007 Jul; 74(2):317-26. PubMed ID: 17517377
[TBL] [Abstract][Full Text] [Related]
20. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling.
Bae YS; Lee HY; Jo EJ; Kim JI; Kang HK; Ye RD; Kwak JY; Ryu SH
J Immunol; 2004 Jul; 173(1):607-14. PubMed ID: 15210823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
